Meeting Banner
Abstract #2386

Advances in 3D High-Speed MR Spectroscopic Imaging for Monitoring Neoadjuvant Chemotherapy in Breast Cancer

Stefan Posse1, Ingrid Lane2, Bruno Sa De La Rocque Guimaraes1, Bernard Twafik3, and Ursa Brown-Glaberman3
1Neurology, University of New Mexico, Albuquerque, NM, United States, 2Mind Research Network, Albuquerque, NM, United States, 3Division of Hematology / Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, United States

Three patients with biopsy-confirmed, infiltrating ductal carcinoma were studied at 3 Tesla to monitor changes in total Choline during neoadjuvant chemotherapy in comparison with dynamic contrast enhanced MRI. A novel bilateral high-speed 3D Proton-Echo-Planar-Spectroscopic-Imaging (PEPSI) protocol with integrated water reference acquisition mapped decreases in total Choline early during treatment in 2 HER2-negative patients with partial pathologic response, but not in the third HER2-positive patient. Surgical clip related B0-inhomogeneity impacted both PEPSI and DCE-MRI measurements. To address this limitation, we developed a novel expanded k-space encoding approach for PEPSI and demonstrated signal recovery in tissue regions affected by dephasing.

This abstract and the presentation materials are available to 2020 meeting attendees and eLibrary customers only; a login is required.

Join Here